BD to Announce Financial Results for Its Third Quarter of Fiscal 2024

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results...

PR NewswireJul 3 20:30

Becton Dickinson Is Maintained at Outperform by Evercore ISI Group

Becton Dickinson Is Maintained at Outperform by Evercore ISI Group

Dow JonesJul 2 23:12

Becton Dickinson Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 24.62% Evercore ISI Group $290 → $285 Maintains Outperform 05/30/2024 19.81% Goldman Sachs → $2

BenzingaJul 2 23:01

Evercore Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $285

Evercore analyst Vijay Kumar maintains $Becton Dickinson & Co(BDX.US)$ with a buy rating, and adjusts the target price from $290 to $285.According to TipRanks data, the analyst has a success rate of 4

Futu NewsJul 2 20:33 · Ratings

Evercore ISI Adjusts Price Target on Becton, Dickinson to $285 From $290, Maintains Outperform Rating

Becton, Dickinson (BDX) has an average outperform rating and a price target range of $240 to $325, according to analysts polled by Capital IQ. Price: 229.86, Change: +0.59, Percent Change: +0.26

MT NewswiresJul 2 19:42

BD's (BDX) New Research Tool to Aid Single-Cell Analysis

Yahoo FinanceJun 28 00:51